Bunkerhill Health · 9 months ago
Sales Development Representative (Remote)
Bunkerhill Health provides a way for researchers to activate their AI algorithms for clinical use, and they are seeking a Sales Development Representative (SDR) to drive revenue growth. The SDR will initiate and nurture relationships with healthcare executives, focusing on proactive outbound prospecting to generate leads.
Artificial Intelligence (AI)Health CareHealth Diagnostics
Responsibilities
Conduct cold calls, emails, LinkedIn outreach, and market research to generate leads at the top of the sales funnel
Maintain and update comprehensive records of all activities, opportunities, and account information within our CRM system
Consistently achieve monthly quotas for qualified meetings and progress pipeline metrics
Qualification
Required
Strong Communication Skills: Engage effectively with healthcare executives (CEOs, COOs, CFOs, CMIOs, CIOs, and service line directors), quickly grasp healthcare terminology, and understand customer needs
Self-driven Mindset: Embrace our fast-paced startup environment and take ownership of your role
Out-of-the-box thinker: Differentiate us from competitors through innovative thinking, rapid iteration, and compelling messaging
Hunger for success: Significant bonuses tied to performance demonstrate our commitment to rewarding your dedication
Embrace challenges: Own your success, learn from the roadblocks, and continue to grow
Preferred
1-2 years in outbound-focused sales
Familiarity with CRM usage, LinkedIn Sales Navigator, and other outreach tools
Strong written communication, phone, presentation, and interpersonal skills
Ability to work independently, create compelling email campaigns, and articulate complex topics
Excellent listening skills, investigative ability, and storytelling prowess
Strong organizational skills and effective time management
Benefits
Comprehensive Health, Dental, and Vision Benefits
401K
Company
Bunkerhill Health
Ask anything about your patients. Automate what happens next.
Funding
Current Stage
Early StageTotal Funding
$30M2023-07-01Series A· $30M
2022-12-01Seed
2020-12-01Pre Seed
Recent News
Business Wire
2025-12-02
BioWorld Financial Watch
2025-09-24
Company data provided by crunchbase